AT376220B - Verfahren zur herstellung neuer 1,4-dihydropyridinderivate - Google Patents

Verfahren zur herstellung neuer 1,4-dihydropyridinderivate

Info

Publication number
AT376220B
AT376220B AT0443178A AT443178A AT376220B AT 376220 B AT376220 B AT 376220B AT 0443178 A AT0443178 A AT 0443178A AT 443178 A AT443178 A AT 443178A AT 376220 B AT376220 B AT 376220B
Authority
AT
Austria
Prior art keywords
producing new
dihydropyridine derivatives
dihydropyridine
derivatives
producing
Prior art date
Application number
AT0443178A
Other languages
German (de)
English (en)
Other versions
ATA443178A (de
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of ATA443178A publication Critical patent/ATA443178A/de
Application granted granted Critical
Publication of AT376220B publication Critical patent/AT376220B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT0443178A 1977-06-20 1978-06-19 Verfahren zur herstellung neuer 1,4-dihydropyridinderivate AT376220B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH752077 1977-06-20
CH286578 1978-03-16

Publications (2)

Publication Number Publication Date
ATA443178A ATA443178A (de) 1984-03-15
AT376220B true AT376220B (de) 1984-10-25

Family

ID=25691589

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0443178A AT376220B (de) 1977-06-20 1978-06-19 Verfahren zur herstellung neuer 1,4-dihydropyridinderivate

Country Status (20)

Country Link
EP (1) EP0000150B1 (xx)
JP (1) JPS54103876A (xx)
AT (1) AT376220B (xx)
AU (1) AU524000B2 (xx)
CA (1) CA1105463A (xx)
CY (1) CY1239A (xx)
DE (1) DE2860708D1 (xx)
DK (1) DK149855C (xx)
ES (1) ES470917A1 (xx)
FI (1) FI64938C (xx)
HK (1) HK65184A (xx)
IE (1) IE47212B1 (xx)
IL (1) IL54948A (xx)
IT (1) IT1105364B (xx)
LU (1) LU88342I2 (xx)
MY (1) MY8500041A (xx)
NL (1) NL930126I2 (xx)
NZ (1) NZ187617A (xx)
PT (1) PT68191A (xx)
SG (1) SG20584G (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH639659A5 (de) * 1978-12-18 1983-11-30 Sandoz Ag Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung.
DK525179A (da) * 1978-12-18 1980-06-19 Sandoz Ag Fremgangsmaade til fremstilling af benzoxadiazoler og benzothiazoler
BE886259A (fr) * 1979-11-23 1981-05-20 Sandoz Sa Nouveaux medicament a base de derives de la 1,4-dihydropyridine, pour le traitement de l'insuffisance cerebrovasculaire ou a action spamolytique
CH655658B (xx) * 1980-09-18 1986-05-15
FI813460L (fi) * 1980-11-10 1982-05-11 Sandoz Ag Nya 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-pyridinderivat deras framstaellningsfoerfarande och dessa innehaollande farmaceutiska kompositioner
EP0080220B1 (en) * 1981-11-17 1986-02-19 FISONS plc Dihydropyridines, methods for their production and their formulation and use as pharmaceuticals
DE3207982A1 (de) * 1982-03-05 1983-09-08 Bayer Ag, 5090 Leverkusen Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln
ZA83959B (en) * 1982-03-10 1984-09-26 Sandoz Ltd 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
DE3208628A1 (de) * 1982-03-10 1983-09-22 Bayer Ag, 5090 Leverkusen Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
FR2528431B1 (fr) * 1982-06-15 1986-01-10 Sandoz Sa Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation comme medicaments
FR2554109A1 (fr) * 1983-11-01 1985-05-03 Sandoz Sa Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation en therapeutique comme medicaments
IE57810B1 (en) * 1984-03-27 1993-04-21 Delagrange Lab 1,4-dihydropyridine derivatives,their preparation and their use
HU198844B (en) * 1984-06-14 1989-12-28 Sandoz Ag Process for producing new galenic pharmaceutical composition ensuring retarded release of active ingredient
US5260321A (en) * 1984-11-12 1993-11-09 Sandoz Ltd. Use of 1,4-dihydropyridine derivatives and combinations thereof with calcitonins
GB8428552D0 (en) * 1984-11-12 1984-12-19 Sandoz Ltd Organic compounds
GB8616047D0 (en) * 1986-07-01 1986-08-06 Sandoz Ltd A 1 4-dihydropyridine derivatives
IL163666A0 (en) 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Active agent delivery systems and methods for protecting and administering active agents

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2629892A1 (de) * 1975-07-02 1977-01-27 Fujisawa Pharmaceutical Co 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2629892A1 (de) * 1975-07-02 1977-01-27 Fujisawa Pharmaceutical Co 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel

Also Published As

Publication number Publication date
FI781867A (fi) 1978-12-21
AU524000B2 (en) 1982-08-26
EP0000150B1 (en) 1981-05-20
JPS6360755B2 (xx) 1988-11-25
CY1239A (en) 1984-06-29
LU88342I2 (fr) 1994-05-04
DK149855B (da) 1986-10-13
FI64938C (fi) 1984-02-10
NZ187617A (en) 1980-12-19
NL930126I2 (nl) 1995-02-16
PT68191A (fr) 1978-07-01
FI64938B (fi) 1983-10-31
DK149855C (da) 1987-04-21
AU3725278A (en) 1980-01-03
SG20584G (en) 1985-03-08
IT1105364B (it) 1985-10-28
IL54948A0 (en) 1978-08-31
IE781231L (en) 1978-12-20
HK65184A (en) 1984-08-31
IE47212B1 (en) 1984-01-25
ES470917A1 (es) 1979-10-01
DE2860708D1 (en) 1981-08-27
DK262578A (da) 1978-12-21
ATA443178A (de) 1984-03-15
NL930126I1 (nl) 1993-11-01
CA1105463A (en) 1981-07-21
IT7849939A0 (it) 1978-06-19
EP0000150A1 (en) 1979-01-10
IL54948A (en) 1982-01-31
MY8500041A (en) 1985-12-31
JPS54103876A (en) 1979-08-15

Similar Documents

Publication Publication Date Title
AT362364B (de) Verfahren zur herstellung neuer phenylimi- dazolidinonderivate
AT376220B (de) Verfahren zur herstellung neuer 1,4-dihydropyridinderivate
AT355041B (de) Verfahren zur herstellung neuer n,n'-thio-bis- oximcarbamate
LU79235A1 (de) Verfahren zur herstellung neuer pyridinyl-aminoalkylaethern
ATA557078A (de) Verfahren zur herstellung neuer 2-formylchinoxalin-1,4-dioxid-zyanacetylhydrazo e
AT379144B (de) Verfahren zur herstellung neuer 4,5-ungesaettigter 16-hydroxyprostansaeurederivate
AT358601B (de) Verfahren zur herstellung neuer nitrosoharn- stoff-derivate
AT367403B (de) Verfahren zur herstellung neuer chinolin-2onderivate
AT355036B (de) Verfahren zur herstellung neuer 1,2,6- thiadiazin-4-one
ATA59078A (de) Verfahren zur herstellung neuer n-9,10-dihydolysergyl-m-aminobenzoesaeurederivate
AT357551B (de) Verfahren zur herstellung neuer azetidinon- derivate
AT368504B (de) Verfahren zur herstellung neuer 4-phenyl-thieno- (2,3-c)-piperidine
ATA90478A (de) Verfahren zur herstellung neuer everninomicin- derivate
AT361640B (de) Verfahren zur herstellung neuer 3beta-substi- tuierter 18-beta-olean-9-en-30-oylsaeure- derivate
AT356294B (de) Verfahren zur herstellung neuer ergolinderivate
AT360998B (de) Verfahren zur herstellung neuer n-pyrimidinyl- -imidsaeureester
AT357516B (de) Verfahren zur herstellung neuer 2,3-dihydro- benzofuranon-2-derivate
AT365606B (de) Verfahren zur herstellung neuer 1,6-anhydro-beta- d-hexopyranosederivate
ATA227183A (de) Verfahren zur herstellung neuer 2-hydroxymethyl -3,4,5-trihydroxypiperidinderivate
ATA533181A (de) Verfahren zur herstellung neuer 2-hydroxymethyl -3,4,5-trihydroxypiperidinderivate
PT67639A (de) Verfahren zur herstellung neuer indolylglyoxylsaeurederivate
ATA415383A (de) Verfahren zur herstellung neuer 2-hydroxymethyl-3,4,5-trihydroxypiperidinderiva e
ATA590179A (de) Verfahren zur herstellung neuer 2-aminotetraline
ATA421180A (de) Verfahren zur herstellung neuer 1,6-anhydro-beta-d-hexopyranosederivate
AT373240B (de) Verfahren zur herstellung neuer pyridyloxyphenoxyalkancarbonsaeurederivate

Legal Events

Date Code Title Description
SZA Application filed for a certificate of protection

Free format text: SZ70/94, 941207

EZF Grant of a certificate of protection

Free format text: SZ 70/94, 941207, EXPIRES:20070315

ELA Expired due to lapse of time